Cargando…

Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN

PURPOSE: Our research aimed to investigate the expression level of circ_0002232, which is transcribed from PTEN, and find out the association of circ_0002232/miR-92a-3p/PTEN network in acute myeloid leukemia (AML). METHODS: Circ_0002232 expression in 115 AML patients and 48 controls was detected by...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Xiao-Yu, Zhao, Qian, Ke, Jin-Ming, Wu, De-Hong, Zhu, Xin, Lin, Jiang, Deng, Zhao-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682446/
https://www.ncbi.nlm.nih.gov/pubmed/33239917
http://dx.doi.org/10.2147/CMAR.S278499
_version_ 1783612687582756864
author Su, Xiao-Yu
Zhao, Qian
Ke, Jin-Ming
Wu, De-Hong
Zhu, Xin
Lin, Jiang
Deng, Zhao-Qun
author_facet Su, Xiao-Yu
Zhao, Qian
Ke, Jin-Ming
Wu, De-Hong
Zhu, Xin
Lin, Jiang
Deng, Zhao-Qun
author_sort Su, Xiao-Yu
collection PubMed
description PURPOSE: Our research aimed to investigate the expression level of circ_0002232, which is transcribed from PTEN, and find out the association of circ_0002232/miR-92a-3p/PTEN network in acute myeloid leukemia (AML). METHODS: Circ_0002232 expression in 115 AML patients and 48 controls was detected by using real-time quantitative PCR. The diagnostic value of circ_0002232 expression was evaluated by receiver operating characteristic curve. Kaplan–Meier curves were used to analyse the impact of circ_0002232 for overall survival. Associated network of circ_0002232 was predicted by using interaction prediction websites. RESULTS: Compared with controls, circ_0002232 was notably low-expressed in AML (P<0.001). According to the result of receiver operating characteristic curve, circ_0002232 expression could distinguish AML patients from controls (P<0.001). There were significant differences in patients’ age (P=0.004), FAB classifications (P=0.036), white blood cell count (P=0.041) and platelet count (P=0.021) between low-expressed circ_0002232 group and high-expressed circ_0002232 group. Moreover, there was a positive correlation between circ_0002232 expression and patients’ age (Pearson r=0.256, P=0.0057). Interestingly, we found that patients in low-expressed circ_0002232 group had better overall survival both in whole AML (P=0.030) and non-APL AML (P=0.014). Remarkably, the expression of circ_0002232 was positively correlated with PTEN (Spearman r=0.678, P<0.001). Furthermore, there was a negative correlation in AML between circ_0002232 and miR-92a-3p (Spearman r=−0.301, P=0.016), miR-92a-3p and PTEN (Spearman r=−0.324, P=0.034). Interaction prediction websites revealed that circ_0002232 might affect the expression of PTEN and the process of AML through sponging miR-92a-3p. CONCLUSION: Circ_0002232, one of the circRNAs transcribed from PTEN, was remarkably down-regulated in AML and could act as a promising biomarker for the diagnosis of AML. In addition, there might be a potential association network of circ_0002232/miR-92a-3p/PTEN in AML.
format Online
Article
Text
id pubmed-7682446
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76824462020-11-24 Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN Su, Xiao-Yu Zhao, Qian Ke, Jin-Ming Wu, De-Hong Zhu, Xin Lin, Jiang Deng, Zhao-Qun Cancer Manag Res Original Research PURPOSE: Our research aimed to investigate the expression level of circ_0002232, which is transcribed from PTEN, and find out the association of circ_0002232/miR-92a-3p/PTEN network in acute myeloid leukemia (AML). METHODS: Circ_0002232 expression in 115 AML patients and 48 controls was detected by using real-time quantitative PCR. The diagnostic value of circ_0002232 expression was evaluated by receiver operating characteristic curve. Kaplan–Meier curves were used to analyse the impact of circ_0002232 for overall survival. Associated network of circ_0002232 was predicted by using interaction prediction websites. RESULTS: Compared with controls, circ_0002232 was notably low-expressed in AML (P<0.001). According to the result of receiver operating characteristic curve, circ_0002232 expression could distinguish AML patients from controls (P<0.001). There were significant differences in patients’ age (P=0.004), FAB classifications (P=0.036), white blood cell count (P=0.041) and platelet count (P=0.021) between low-expressed circ_0002232 group and high-expressed circ_0002232 group. Moreover, there was a positive correlation between circ_0002232 expression and patients’ age (Pearson r=0.256, P=0.0057). Interestingly, we found that patients in low-expressed circ_0002232 group had better overall survival both in whole AML (P=0.030) and non-APL AML (P=0.014). Remarkably, the expression of circ_0002232 was positively correlated with PTEN (Spearman r=0.678, P<0.001). Furthermore, there was a negative correlation in AML between circ_0002232 and miR-92a-3p (Spearman r=−0.301, P=0.016), miR-92a-3p and PTEN (Spearman r=−0.324, P=0.034). Interaction prediction websites revealed that circ_0002232 might affect the expression of PTEN and the process of AML through sponging miR-92a-3p. CONCLUSION: Circ_0002232, one of the circRNAs transcribed from PTEN, was remarkably down-regulated in AML and could act as a promising biomarker for the diagnosis of AML. In addition, there might be a potential association network of circ_0002232/miR-92a-3p/PTEN in AML. Dove 2020-11-19 /pmc/articles/PMC7682446/ /pubmed/33239917 http://dx.doi.org/10.2147/CMAR.S278499 Text en © 2020 Su et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Su, Xiao-Yu
Zhao, Qian
Ke, Jin-Ming
Wu, De-Hong
Zhu, Xin
Lin, Jiang
Deng, Zhao-Qun
Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title_full Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title_fullStr Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title_full_unstemmed Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title_short Circ_0002232 Acts as a Potential Biomarker for AML and Reveals a Potential ceRNA Network of Circ_0002232/miR-92a-3p/PTEN
title_sort circ_0002232 acts as a potential biomarker for aml and reveals a potential cerna network of circ_0002232/mir-92a-3p/pten
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682446/
https://www.ncbi.nlm.nih.gov/pubmed/33239917
http://dx.doi.org/10.2147/CMAR.S278499
work_keys_str_mv AT suxiaoyu circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT zhaoqian circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT kejinming circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT wudehong circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT zhuxin circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT linjiang circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten
AT dengzhaoqun circ0002232actsasapotentialbiomarkerforamlandrevealsapotentialcernanetworkofcirc0002232mir92a3ppten